When you read this is sounds pretty dramatic, but the procedure is working. Family *** donors are needed. This is another hospital acquired infection that is growing almost as fast as MRSA and one to be aware of. The process involves a stool transplant and is running about a 95% cure...
Posted to
The Medical Quack .... by Barbara Duck
on 10-30-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Hospital, R and D, C Diff, bacteria, stool transplant, Hospial acquired infections
We probably have all heard of MRSA, the staph infection that is running running through all our hospitals in the US, but there's another one to be aware of, called C diff for short. It can exist on surfaces for months. Canada and the UK have been in the news recently on their fight against...
Posted to
The Medical Quack .... by Barbara Duck
on 09-15-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Hospital, C Diff, infectious disease, hospital acquired infections, Clostridium difficile, Superbug
This is hot stuff! Recently I had an in depth interview with Dr. Patrice Milos, Chief Scientific Officer at Helicos discussing genomics and where the future is going. Helicos has the software and the genomics machine, and wouldn't this be a nice addition to run on Surface. This...
Posted to
The Medical Quack .... by Barbara Duck
on 08-27-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Microsoft/Windows News, Hospital, Genomics, healthcare, microsoft, Surface, Cardiology, Touch Screen, HIMMS, Surface Technology, Helicos, Heart Transplant, MSDN, Scripps, Healthblog
This appears to be a replacement to the scalpel as known today. Less bleeding and better control are some of the benefits for surgeons. This gives the best of both worlds to the surgeon it appears. Other devices on the market also control bleeding but potentially cause additional tissue...
Dennis Quaid is continuing his efforts for better safety in taking a tour of a hospital in Dallas that is using a bar coding system. Hat’s off for his continued efforts and taking the time to find out what’s available out there. As everyone remembers his 2 children had staff infections and...
With all the new breakthroughs in cardiology with the removal of plaque, soon this could be a worry of the past. The product won’t be on the market until later this year. The process of “roto-rootering” plaque is making some huge leaps and bounds today to clear arteries and bring arterial...
The cardiovascular point of care tests will be marketed by Roche Diagnostics. The test will located elevated levels of the markers for BNP, which are indicators for heart failure. A very sophisticated technology that will allow for hospitals to check with a simple test to see if a patient...